Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 16,526–16,550 of 27,380 studies, newest first · page 662 of 1096.

November 2015 25

  1. 2015-11-30

    How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?

    ✓ Peer-reviewed Cognitive tests and assessment The Clinical neuropsychologist

    Key finding: Clinicians and researchers who measure cognitive dysfunction often use the Alzheimer's Disease Assessment Scale--Cognitive Subscale (ADAS-Cog), the Mini-Mental State Examination (MMSE), or the Clinical Dementia Rating scale (CDR-SOB). +3 more findings

  2. 2015-11-30

    DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice

    ✓ Peer-reviewed Risk genes beyond APOE Nature communications

    Key finding: Defective DNA repair may contribute to neurological disorders, including Alzheimer's disease (AD). +3 more findings

  3. 2015-11-29

    Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review

    ✓ Peer-reviewed Clinical safety BioMed research international

    Key finding: Studies are heterogeneous in many aspects, including size sample, intervention, and instruments of measures. +2 more findings

  4. 2015-11-28

    The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials

    ✓ Peer-reviewed Getting a diagnosis Ageing research reviews

    Key finding: The primary analysis yielded a positive overall effect of physical activity interventions on cognitive function (SMD[95% confidence interval]=0.42[0.23;0.62], p<.01). +3 more findings

  5. 2015-11-27

    Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level

    ✓ Peer-reviewed Drug development Molecular and cellular neurosciences

    Key finding: We found that peripheral ex-4 injection in T2D rats reduced hyperphosphorylation of tau protein in rat hippocampus, probably via increasing hippocampal insulin which activated insulin signaling. +2 more findings

  6. 2015-11-27

    Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer's Disease

    ✓ Peer-reviewed Biomarkers Frontiers in neurology

    Key finding: Previous studies showed significant heterogeneity in CSF Aβ42 levels to discriminate AD from non-AD patients. +1 more finding

  7. 2015-11-27

    Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1

    ✓ Peer-reviewed Risk genes beyond APOE Molecular neurobiology

    Key finding: We performed the meta-analysis to obtain a more precise estimation of whether growth factor receptor-bound protein-associated binding protein 2 (GAB2), phosphatidylinositol binding clathrin assembly protein (PICALM), and sortilin-related receptor (SORL1) variants are associated with AD. +4 more findings

  8. 2015-11-26

    Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases

    ✓ Peer-reviewed Disease mechanisms Pharmacology & therapeutics

    Key finding: The gut microbiome comprises the collective genome of the trillions of microorganisms residing in our gastrointestinal ecosystem. +3 more findings

  9. 2015-11-26

    Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease

    ✓ Peer-reviewed How common it is Mediators of inflammation

    Key finding: As a cause or consequence, the chronic inflammatory response and oxidative stress associated with T2DM, amyloid-β (Aβ) protein accumulation, and mitochondrial dysfunction link T2DM and AD.

  10. 2015-11-24

    Intensive care at the end of life in patients dying due to non-cancer chronic diseases versus cancer: a nationwide study in Denmark

    ✓ Peer-reviewed End-of-life care Critical care (London, England)

    Key finding: Overall, patients dying as a result of non-cancer diseases were twice as likely to be admitted to ICUs at the EOL as patients dying due to cancer. +4 more findings

  11. 2015-11-22

    From eyeless to neurological diseases

    ✓ Peer-reviewed Brain scans and imaging Experimental eye research

    Key finding: Age-related cataracts are frequently associated with degenerative changes in the ocular lens including the aggregation of proteins - mainly crystallins, but also other proteins including amyloids (Aβ) leading to the hypothesis that cataracts could be used as "biomarkers" for Alzheimer disease. +2 more findings

  12. 2015-11-22
  13. 2015-11-21

    Neurotoxicity of traffic-related air pollution

    ✓ Peer-reviewed Risk factors Neurotoxicology

    Key finding: Human epidemiological studies and controlled animal studies have shown that exposure to air pollution, and to traffic-related air pollution or DE in particular, may lead to neurotoxicity.

  14. 2015-11-20

    Do determinants of burden and emotional distress in dementia caregivers change over time?

    ✓ Peer-reviewed Caregiving Aging & mental health

    Key finding: General burden is shown to be determined by severity of patient's neuropsychiatric symptoms, caregiver's sense of competence, health-related quality of life. +2 more findings

  15. 2015-11-20

    Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease

    ✓ Peer-reviewed Inflammation and the immune system Annals of clinical and translational neurology

    Key finding: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non-AD dementias. +3 more findings

  16. 2015-11-20

    Domain-specific versus generalized cognitive screening in acute stroke

    ✓ Peer-reviewed Cognitive tests and assessment Journal of neurology

    Key finding: The Oxford Cognitive Screen (OCS) provides a domain-specific cognitive profile designed for stroke survivors. +3 more findings

  17. 2015-11-19

    Cascading network failure across the Alzheimer's disease spectrum

    ✓ Peer-reviewed Brain scans and imaging Brain : a journal of neurology

    Key finding: The two main findings of this paper are (i) the posterior default mode network fails before measurable amyloid plaques and appears to initiate a connectivity cascade that continues throughout the disease spectrum; and (ii) high connectivity between the posterior default mode network and hubs of high connectivity (many located in the frontal lobe) is associated with amyloid accumulation. +1 more finding

  18. 2015-11-19

    Cerebral Vasoreactivity, Apolipoprotein E, and the Risk of Dementia: A Population-Based Study

    ✓ Peer-reviewed Long-term cohort studies Arteriosclerosis, thrombosis, and vascular biology

    Key finding: Cerebral vasoreactivity (CVR) is a key factor in maintenance of continuous cerebral perfusion and a marker of (micro)vascular damage. +3 more findings

  19. 2015-11-19

    Aging in Taiwan: Building a Society for Active Aging and Aging in Place

    ✓ Peer-reviewed Disparities The Gerontologist

    Key finding: Taiwan's accelerated rate of aging is more than twice that of European countries and United States. +4 more findings

  20. 2015-11-19

    Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment

    ✓ Peer-reviewed Biomarkers Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Key finding: Both (18)F-FDG and (11)C-PiB imaging appear to be of limited use for predicting the progression from MCI to dementia due to AD in short-term follow-up, irrespective of the strategy of analysis. +2 more findings

  21. 2015-11-18

    The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

    ✓ Peer-reviewed Inflammation and the immune system Journal of neurochemistry

    Key finding: Deposition of amyloid-β (Aβ) remains a hallmark feature of the disease, yet the precise mechanism(s) by which this peptide induces neurotoxicity remain unknown. +3 more findings

  22. 2015-11-17

    Pomegranate's Neuroprotective Effects against Alzheimer's Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites

    ✓ Peer-reviewed Disease mechanisms ACS chemical neuroscience

    Key finding: In silico computational studies, used to predict blood-brain barrier permeability, revealed that none of the PE constituents, but the urolithins, fulfilled criteria required for penetration.

  23. 2015-11-17

    A systematic review of reasons for gatekeeping in palliative care research

    ✓ Peer-reviewed End-of-life care Palliative medicine

    Key finding: Gatekeeping is motivated by the general assumption of vulnerability of patients, coupled with an emphasis on the duty to protect patients.

  24. 2015-11-17

    Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial

    ✓ Peer-reviewed Prevention trials International psychogeriatrics

    Key finding: These findings challenge current management practices of Alzheimer's patients. +3 more findings

  25. 2015-11-17

    The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of Life

    ✓ Peer-reviewed Costs and economics Annals of Internal Medicine

    Key finding: Average total cost per dementia decedent was $287,038 over the last 5 years of life, higher than for heart disease, cancer, or other causes +3 more findings

Browse the library by subject, with the full score breakdown →